User:LittleA65/sandbox

Professor Ian Charles is an internationally recognised scientist with expertise in infectious diseases and the microbiome and its impact on health and well-being.

Prof. Charles is currently Director of the Quadram Institute, Norwich, UK. The organisation's mission is to deliver healthier lives through innovation in gut health, microbiology and food. It is a partnership between Quadram Institute Bioscience, the Norfolk and Norwich University Hospitals NHS Foundation Trust, the University of East Anglia and the Biotechnology and Biological Sciences Research Council (BBSRC).

Education

 * 1977 – 1980, University of St Andrews, Scotland, Zoology
 * 1981 – 1985, University of Leicester, UK - PhD, Biochemistry

Research
Prof. Charles ' research interests lie in the areas of infectious diseases and the microbiome and their impact on human health.

Career
Prior to becoming Director of the Quadram Institute, Norwich, UK, Professor Charles was Director of ithree institute in Sydney, Australia, and visiting Professor at University of Technology, Sydney. He has been Professor of Molecular Biology at University of Sheffield and University College London, UK. In 1995 he was a founding member of the Wolfson Institute for BioMedical Research at University College London, one the UK’s first institutes of translational biomedical research.

Prof. Charles founded two anti-infectives drug discovery companies. Arrow Therapeutics, sold to AstraZeneca in 2007, and Auspherix founded in 2013. He is currently a Non-Executive Director for Genus plc, and also Co-Founder, Director and Scientific Advisor at Longas Technologies. His earlier commercial career included being Head of Molecular Pharmacology at Glaxo Wellcome; and Senior Research Scientist at Wellcome Research Laboratories.